FDA OKs new generation Boston Scientific heart pacing devices

April 15, 2014 9:35 PM

10 0

FDA OKs new generation Boston Scientific heart pacing devices

(Reuters) - U.S. health regulators have approved four Boston Scientific Corp implantable devices for heart patients, including a next generation of smaller defibrillators to treat abnormal heart rhythms, the company said on Tuesday.

The Food and Drug Administration approved for sale the Dynagen Mini and Inogen Mini ICDs and the Dynagen X4 and Inogen X4 CRT-Ds, Boston Scientific said.

Read more

To category page

Loading...